Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Nanostructured lipid carriers can improve androgenic alopecia treatment by reducing dutasteride dosage and maintaining its presence in hair follicles longer.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

The normalized androgen ratio can help manage conditions with excess androgen activity in women.

Synthetic hormone treatment reduces melanin and hair growth in rats.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

The niosomal gel effectively delivers testosterone through the skin with fewer side effects.

A man had bad reactions to a hair loss treatment called DNCB.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Changing neuroactive steroids in baby male rats affects their memory and learning differently as they grow up.

Neurosteroids help control dopamine responses in the brain.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Researchers made two new compounds that could be used for medicine.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Detecting steroid esters in cattle hair is inconsistent and influenced by sampling factors.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Finasteride in lipid carriers improved hair growth in rats.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.